- Explain guidelines for additional therapies for patients on maximally tolerated statin therapy.
- Understand the pathogenesis of lipid metabolism and ASCVD.
- Recognize the undertreatment of lipid disorders in patients with PAD
06/30/2022 - 7:30am to 8:30am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Michael Davidson, MD